ADT-3

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameADT-3
Drug Alias NameADT-3
ClassificationBiologics > T cell engagers
Mechanisms of ActionAnti-Epidermal growth factor receptor erbB1T-cell receptor modulators
TargetsEpidermal growth factor receptor erbB1T-cell receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdaptate Biotherapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAdaptate Biotherapeutics Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A